The Extrapancreatic Effects of Glucagon-Like Peptide-1 and Related Peptides
AUTOR(ES)
Abu-Hamdah, Rania
FONTE
The Endocrine Society
RESUMO
Context: Glucagon-like peptide-1 (GLP-1) 7-36 amide, an insulinotropic hormone released from the intestinal L cells in response to nutrient ingestion, has been extensively reviewed with respect to β-cell function. However GLP-1 receptors are abundant in many other tissues. Thus, the function of GLP-1 is not limited to the islet cells, and it has regulatory actions on many other organs.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2690432Documentos Relacionados
- Glucagon-like peptide-1 (GLP-1): a piece of the incretin puzzle.
- Glucagon-like peptide-1 is a physiological incretin in rat.
- Glucagon-like peptide-1 can reverse the age-related decline in glucose tolerance in rats.
- Differences in the Central Anorectic Effects of Glucagon-Like Peptide-1 and Exendin-4 in Rats
- Ingestion of Diet Soda Before a Glucose Load Augments Glucagon-Like Peptide-1 Secretion
